Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why I Bought Shares of This Genetics Company

TheMotleyFool

0 0

Here's Why I Bought Shares of This Genetics Company

We recently learned that home DNA-testing company 23andMe will be going public through a merger with special purpose acquisition company (SPAC) VG Acquisition Corp (NYSE: VGAC). In this Fool Live video clip, recorded on March 15, Fool.com contributor Matt Frankel, CFP, explains to Industry Focus host Jason Moser why he owns shares of this high-potential genetics company in his personal stock portfolio, specifically in the context of their pharmaceutical development potential.

Source Fool.com

Like: 0

VGAC

Share